
To safeguard patient access to life-saving medications, pharma companies must prioritize building robust resilience strategies that encompass IT systems, inventory management, risk mitigation, and regulatory compliance.

Head of Healthcare and Life Sciences, Zensar

Published: August 15th 2024 | Updated: